Adamant | Awards

	Second place in "Fund Award 2010" for the Lacuna Adamant Asia Pacific Health "Euro" magazine awarded funds with focus on the healthcare and pharma industry.
	Runner-Up at the "Swiss Derivative Awards 2008" The certificates based on the ABN AMRO/Adamant Healthcare Momentum Index were awarded second rank in the category "Participation-Products".
	Runner-Up at the Trophée Bilan 2008 Swiss Life Funds Equity Biomedical was rated second rank in the category "Santé & Environnement".
	Standard & Poor's "AA" Rating 2003, 2004, 2005, 2006, 2007 and 2008 Adamant received "AA" Rating for the Lacuna SICAV – Lacuna Apo BioTech fund.
	"Fonds des Jahres 2007", 3rd rank The Lacuna SICAV – Lacuna Apo BioTech fund was awarded third rank by the "€uro" magazine in the category "Equity Fund" with focus on biotechnology.
	Lipper Awards 2005 for Switzerland and Europe The Swiss Life (LUX) – Equity Biomedical Fund was rated best biotech fund in Switzerland and Europe over three years.
	“Fonds des Jahres 2003”, 1st rank "Finanzen" and "Euro am Sonntag" awarded the Lacuna SICAV – Lacuna ApoBiotech with first rank in the category "Pharma and Health".
	Adamant in the finals of the "Entrepreneur of the year 2004" in Switzerland Ernst&Young awarded companies for their "superior growth and exceptional spirit of innovation".